Q3 2023 ImpediMed Ltd Activities Report Call Transcript
Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results Conference Call and Investor presentation. (Operator Instructions) I would now like to hand the conference over to Mr. Rick Valencia, Managing Director and Chief Executive Officer. Please go ahead.
Thank you, Winnie, and welcome, everybody, to our third quarter 4C and investor presentation. We've got some good updates for you. We've got 3 key updates that we want to cover today.
First of all, as we talked about a few weeks ago, the NCCN survivorship guidelines were updated very favorably for us. And that has turned into a very transformative moment for the company in a number of ways, and we're going to get into a little bit more detail as to how after we give you a third quarter update in a few minutes.
We're also achieving significant momentum with payers in the U.S. We talked a bit about that, and I believe some folks were a bit frustrated that we couldn't give you a little bit more detail around
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |